A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)

Adult Leukemia ◽

Leukemia Group ◽

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Annals of Hematology ◽

10.1007/s00277-005-1046-0 ◽

2005 ◽

Vol 84 (9) ◽

pp. 557-564 ◽

Cited By ~ 27

Author(s):

A. Wrzesień-Kuś ◽

T. Robak ◽

A. Wierzbowska ◽

E. Lech-Marańda ◽

A. Pluta ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Adult Leukemia ◽

Leukemia Group ◽

Stimulating Factor ◽

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

Leukemia ◽

10.1038/sj.leu.2400905 ◽

1998 ◽

Vol 12 (2) ◽

pp. 139-143 ◽

Cited By ~ 9

Author(s):

EJ Lee ◽

SL George ◽

PC Amrein ◽

PA Paciucci ◽

SL Allen ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Group B ◽

Leukemia Group ◽

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Case Medical Research ◽

10.31525/ct1-nct03839446 ◽

2000 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Induction Therapy ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Gemtuzumab Ozogamicin ◽

Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study

Annals of Hematology ◽

10.1007/s00277-007-0421-4 ◽

2007 ◽

Vol 87 (5) ◽

pp. 361-367 ◽

Cited By ~ 10

Author(s):

Jerzy Hołowiecki ◽

Sebastian Grosicki ◽

Sławomira Kyrcz-Krzemien ◽

Aleksander B. Skotnicki ◽

Beata Piatkowska-Jakubas ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Pilot Study ◽

Myeloid Leukemia ◽

Remission Induction ◽

Early Outcome ◽

Adult Leukemia ◽

Leukemia Group ◽

A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia

European Journal Of Haematology ◽

10.1111/ejh.13544 ◽

2020 ◽

Author(s):

Jonathan Canaani ◽

Ivetta Danylesko ◽

Noga Shemtov ◽

Maya Zlotnick ◽

Kira Lozinsky ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.09.007 ◽

2017 ◽

Vol 17 (12) ◽

pp. 902-907 ◽

Cited By ~ 3

Author(s):

Abu-Sayeef Mirza ◽

Jeffrey E. Lancet ◽

Kendra Sweet ◽

Eric Padron ◽

Javier Pinilla-Ibarz ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Imatinib Mesylate ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

PF261 A RANDOMIZED, OPEN-LABEL, PHASE II STUDY OF SELINEXOR VERSUS PHYSICIAN'S CHOICE (PC) IN OLDER PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

HemaSphere ◽

10.1097/01.hs9.0000559256.03686.3a ◽

2019 ◽

Vol 3 (S1) ◽

pp. 82-83 ◽

Cited By ~ 1

Author(s):

K. Sweet ◽

W. Blum ◽

H. Donner ◽

I. Flinn ◽

O. Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.03.033 ◽

2011 ◽

Vol 11 (5) ◽

pp. 433-438 ◽

Cited By ~ 38

Author(s):

Aaron D. Schimmer ◽

Wolfgang Herr ◽

Mathias Hänel ◽

Gautham Borthakur ◽

Arthur Frankel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Antisense Oligonucleotide ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Remission Rates ◽

A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1950706 ◽

2021 ◽

pp. 1-12

Author(s):

Kendra Sweet ◽

Bhavana Bhatnagar ◽

Hartmut Döhner ◽

Will Donnellan ◽

Olga Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Journal of Hematology ◽

10.14740/jh771 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1-7

Author(s):

Mary Beth Seegars ◽

Ryan Woods ◽

Leslie R. Ellis ◽

Rupali Roy Bhave ◽

Dianna S. Howard ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Pilot Phase ◽

Vincristine Sulfate ◽